(Total Views: 470)
Posted On: 04/03/2025 11:51:36 AM
Post# of 151876
Standard of Care:
Trodelvy for mTNBC.
Temozolomide for Glioblastoma.
Trodelvy survival 21 months.
Temozolomide survival 20 months.
Ladies of Leronlimab right @ 48.
Leronlimab will be last line SOC.
Pre-clinical proving @ best early-line combo SOC.
On to next steps of Leronlimab!!...
Trodelvy for mTNBC.
Temozolomide for Glioblastoma.
Trodelvy survival 21 months.
Temozolomide survival 20 months.
Ladies of Leronlimab right @ 48.
Leronlimab will be last line SOC.
Pre-clinical proving @ best early-line combo SOC.
On to next steps of Leronlimab!!...
(5)
(0)Scroll down for more posts ▼
